The agency claims intellectual property for emergency allergy shot EpiPen and asthma medication Advair was “improperly listed” in a Food and Drug Administration database.
The agency claims intellectual property for emergency allergy shot EpiPen and asthma medication Advair was “improperly listed” in a Food and Drug Administration database.